Sepsis is a common condition managed in the emergency department. Current diagnosis relies on physiologic criteria and suspicion of a source of infection using history, physical examination, laboratory studies, and imaging studies. The infection triggers a host response with the aim to destroy the pathogen, and this response can be measured. A reliable biomarker for sepsis should assist with earlier diagnosis, improve risk stratification, or improve clinical decision making. Current biomarkers for sepsis include lactate, troponin, and procalcitonin. This article discusses the use of lactate, procalcitonin, troponin, and novel biomarkers for use in sepsis.
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2gQqN2T
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Oral Candida colonization in xerostomic post‐radiotherapy head and neck cancer patients 16h ... Oral Candida colonization in xerostomic post...
-
U.S. Department of Veterans Affairs Research News from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2iVEnBB
-
Clinical application of stress echocardiography for valvular heart disease Abstract Stress echocardiography is widely used to assess several...
-
On March 26th 2018, the New York Times published an article by Gina Kolata, For Many Strokes, There's an Effective Treatment. Why Are...
-
Evidence-based Complementary and Alternative Medicine from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/22UB4wW
-
MedStar replaced training diagrams with drone flyovers of the driving course to better demonstrate how to navigate a complicated driving sc...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου